{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:02:44Z","timestamp":1791806564498,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jcmgh.2019.10.010","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T10:27:43Z","timestamp":1572776863000},"page":"349-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["A Functional Role of GAS6\/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target"],"prefix":"10.1016","volume":"9","author":[{"given":"Anna","family":"Tutusaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"de Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Cucarull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Crist\u00f3bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Arest\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Graupera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-1834","authenticated-orcid":false,"given":"Anna","family":"Colell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gro","family":"Gausdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Lorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-2269","authenticated-orcid":false,"given":"Albert","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Mar\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2019.10.010_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib7","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A\u00a0randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jhep.2014.02.003","article-title":"Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma","volume":"60","author":"Coulouarn","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib13","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1038\/srep07916","article-title":"Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer","volume":"5","author":"Barcena","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1160\/TH08-04-0253","article-title":"Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation","volume":"100","author":"Fernandez-Fernandez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.23833","article-title":"Growth arrest-specific protein 6 is hepatoprotective against murine ischemia\/reperfusion injury","volume":"52","author":"Llacuna","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib18","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1053\/j.gastro.2005.08.004","article-title":"Expression and role of Gas6 protein and of its receptor Axl in hepatic regeneration from oval cells in the rat","volume":"129","author":"Couchie","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2009.02.030","article-title":"Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice","volume":"51","author":"Lafdil","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.21237","article-title":"Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells","volume":"44","author":"Lafdil","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2015.04.013","article-title":"Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation","volume":"63","author":"Barcena","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2015.10.016","article-title":"MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease","volume":"64","author":"Petta","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/hmg\/ddw400","article-title":"MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat","volume":"26","author":"Musso","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2015.11.042","article-title":"Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis","volume":"64","author":"Mari","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nbt0913-775a","article-title":"First Axl inhibitor enters clinical trials","volume":"31","author":"Sheridan","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni.2986","article-title":"Diversification of TAM receptor tyrosine kinase function","volume":"15","author":"Zagorska","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ijo.2017.128","article-title":"Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis","volume":"41","author":"Guo","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib28","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1080\/15548627.2016.1235124","article-title":"Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice","volume":"12","author":"Han","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","article-title":"R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer","volume":"70","author":"Holland","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.1620558114","article-title":"AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses","volume":"114","author":"Richard","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib31","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"Caballero","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib32","doi-asserted-by":"crossref","first-page":"e2464","DOI":"10.1038\/cddis.2016.368","article-title":"Cysteine cathepsins control hepatic NF-kappaB-dependent inflammation via sirtuin-1 regulation","volume":"7","author":"de Mingo","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","article-title":"Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE","volume":"169","author":"Orme","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20151095","article-title":"An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth","volume":"213","author":"Atapattu","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.23250","article-title":"Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice","volume":"51","author":"Fiorentino","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib37","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1038\/cddis.2017.554","article-title":"The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis","volume":"8","author":"Staufer","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib38","doi-asserted-by":"crossref","first-page":"46234","DOI":"10.18632\/oncotarget.17598","article-title":"Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis","volume":"8","author":"Dengler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib39","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/cvr\/cvz100","article-title":"TAM receptors in cardiovascular disease","volume":"115","author":"McShane","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.clinbiochem.2010.04.006","article-title":"Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia","volume":"43","author":"Ekman","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib41","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1164\/rccm.201707-1519OC","article-title":"Targeting of TAM receptors ameliorates fibrotic mechanisms in idiopathic pulmonary fibrosis","volume":"197","author":"Espindola","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-019-0377-8","article-title":"Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation","volume":"17","author":"Lauter","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","article-title":"MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure","volume":"67","author":"Triantafyllou","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib44","doi-asserted-by":"crossref","first-page":"G899","DOI":"10.1152\/ajpgi.00382.2015","article-title":"TAM receptor tyrosine kinase function and the immunopathology of liver disease","volume":"310","author":"Mukherjee","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib45","doi-asserted-by":"crossref","first-page":"105727","DOI":"10.18632\/oncotarget.22394","article-title":"MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib46","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V128.22.2754.2754","article-title":"AXL\/ Mer inhibitor ONO-9330547 as a novel therapeutic agent in a stromal co-culture model of primary acute myeloid leukaemia (AML)","volume":"128","author":"Gilmour","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib47","doi-asserted-by":"crossref","first-page":"89761","DOI":"10.18632\/oncotarget.21125","article-title":"Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-17-1973","article-title":"Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer","volume":"78","author":"Ludwig","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hep.30166","article-title":"Transforming growth factor-beta and Axl induce CXCL5 and neutrophil recruitment in hepatocellular carcinoma","volume":"69","author":"Haider","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib51","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/hep.22753","article-title":"Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential","volume":"49","author":"Moles","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib54","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.10.010_bib55","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/ar4199","article-title":"Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity","volume":"15","author":"Recarte-Pelz","year":"2013","journal-title":"Arthritis Res Ther"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X19301468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X19301468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:23:05Z","timestamp":1762453385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X19301468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["S2352345X19301468"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.010","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Functional Role of GAS6\/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}